ADVENT On Air

ADVENT On Air

By ADVENT ProgramMedicineHealth & Fitness
Download on the App Store

ADVENT On Air episodes

  • First-hand Experience: Practical Insights on the Diagnosis and Assessment of Atopic Dermatitis of the Hands and Feet

    Dr Linda Stein Gold and Dr Jonathan Silverberg discuss the challenges associated with diagnosis of atopic dermatitis of the hands and feet and how disease severity can be assessed in clinical practice.

    ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

    This podcast is intended for healthcare professionals only.


    Disclaimer: 

    • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
    • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
    • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits


      • Speaker disclosures:

      • Dr Jonathan Silverberg: Honoraria as a consultant and/or advisory board member for AbbVie, Alamar, Aldena Therapeutics, Amgen, AOBiome, Apollo Pharma, Arcutis, Arena Pharmaceuticals, Asana, ASLAN Pharmaceuticals, Attovia, BiomX, Biosion, Bodewell, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celgene, Connect Biopharma, CorEvitas, Dermavant, FIDE, Galderma, GSK, Incyte, Invea, Kiniksa, LEO Pharma, Lilly, Merck, MyOr Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT Therapeutics, Recludix, Regeneron, Sandoz, Sanofi-Genzyme, Shaperon, Target RWE, Teva, UNION, and UpToDate. Speaker for AbbVie, LEO Pharma, Lilly, Pfizer, Regeneron, and Sanofi-Genzyme. Institution received grants from Galderma, Incyte, and Pfizer.
      • Dr Linda Stein Gold: Investigator/advisor and/or speaker for AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Dermavant, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi.


        • © 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

        MAT-GLB-2402602- 1.0 - 05/2024

        MAT-US-2405594 v1.0 - P Exp Date: 06/04/2026

        11 min
      • Getting to Grips with Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?

        Dr Linda Stein Gold and Dr Jonathan Silverberg discuss the epidemiology, clinical presentation, and classification of atopic dermatitis of the hand and feet as well the as quantifying the multidimensional burden it has on patients' quality of life in clinical practice.

        ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

        This podcast is intended for healthcare professionals only.


        Disclaimer: 

        • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
        • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
        • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits


          • Speaker disclosures:

          • Dr Jonathan Silverberg: Honoraria as a consultant and/or advisory board member for AbbVie, Alamar, Aldena Therapeutics, Amgen, AOBiome, Apollo Pharma, Arcutis, Arena Pharmaceuticals, Asana, ASLAN Pharmaceuticals, Attovia, BiomX, Biosion, Bodewell, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celgene, Connect Biopharma, CorEvitas, Dermavant, FIDE, Galderma, GSK, Incyte, Invea, Kiniksa, LEO Pharma, Lilly, Merck, MyOr Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT Therapeutics, Recludix, Regeneron, Sandoz, Sanofi-Genzyme, Shaperon, Target RWE, Teva, UNION, and UpToDate. Speaker for AbbVie, LEO Pharma, Lilly, Pfizer, Regeneron, and Sanofi-Genzyme. Institution received grants from Galderma, Incyte, and Pfizer.
          • Dr Linda Stein Gold: Investigator/advisor and/or speaker for AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Dermavant, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi.


            • © 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

            MAT-GLB-2400314 - 1.0 - 06/2024 

            MAT-US-2405589 v1.0 - P Exp Date: 06/04/2026

            18 min
          • The Road Ahead: Achieving Remission for Patients with Asthma

            Join renowned pulmonologists Klaus Rabe, MD, PhD, FERS, and Ian Pavord, DM, FRCP, FERS, as they discuss on-treatment clinical remission as a goal in asthma management beyond disease control, and highlight the role of type 2 inflammatory biomarkers in optimizing patient outcomes.


            ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

            This podcast is intended for healthcare professionals only.


            Disclaimer:

            • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
            • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program.
            • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits.


              • Speaker disclosures:

              • Ian D. Pavord, MA, DM, FRCP, FERS, FMedSci has received honoraria for speaking at sponsored meetings from Astra Zeneca, Boehringer Inglehiem, Aerocrine, Almirall, Novartis, Teva, Chiesi, Sanofi/Regeneron, Menarini and GSK and payments for organising educational events from AZ, GSK, Sanofi/Regeneron and Teva. He has received honoraria for attending advisory panels with Genentech, Sanofi/Regeneron, Astra Zeneca, Boehringer Ingelheim, GSK, Novartis, Teva, Merck, Circassia, Chiesi and Knopp and payments to support FDA approval meetings from GSK. He has received sponsorship to attend international scientific meetings from Boehringer Ingelheim, GSK, Astra Zeneca, Teva and Chiesi. He has received a grant from Chiesi to support a phase 2 clinical trial in Oxford. He is co-patent holder of the rights to the Leicester Cough Questionnaire and has received payments for its use in clinical trials from Merck, Bayer and Insmed. In 2014-5 he was an expert witness for a patent dispute involving Astra Zeneca and Teva. 
              • Klaus Rabe, MD, PhD has served on FDA and EMA panels for registration of drug for COPD. He has served on advisory panels for AstraZeneca, Boehringer Ingelheim, Chiesi Pharmaceuticals, Sanofi & Regeneron, Berlin Chemie, Novartis, GlaxoSmithKline, Insmed, CSL Behring making asthma and COPD drugs, and participated in clinical trials. He has never worked with the tobacco industry (and never will). He has no shares or proprietary interests of any kind.


                • © 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

                MAT-GLB-2303834 V1 02/2024

                MAT-US-2402193 v1.0 - P Expiration Date: 02/26/2026

                16 min
              • What Is the Future Outlook for Remission in Pediatric Severe Asthma?

                Listen to Len Bacharier, MD and Sharon Dell, MD, FRCPC, as they highlight the natural course of pediatric asthma progression over time, discuss differences between spontaneous remission and on-treatment clinical remission, and provide a commentary on what we have learned from the recent developments around remission in adults and how it could relate more specifically to pediatric populations.

                 

                ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

                This podcast is intended for healthcare professionals only.


                Disclaimer: 

                • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
                • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
                • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits


                  • Speaker disclosures:

                  • Len Bacharier, MD has served as an advisor, consultant, speaker, and/or investigator for AstraZeneca, Avillion, DBV Technologies, Genentech/Novartis, GlaxoSmithKline, Kinaset, OM Pharma, Recludix, Regeneron Pharmaceuticals, Inc., Sanofi, Vertex; has provided grant and/or research support for NIH (NHLBI, NIAID), Regeneron Pharmaceuticals, Inc., Sanofi; and has provided other support for DBV Technologies
                  • Sharon Dell, MD has served as an advisor, consultant, and/or speaker for  AstraZeneca, Novartis, Regeneron Pharmaceuticals, Sanofi; and has provided grant and/or research support for Boehringer Ingelheim, Merck, Parion Sciences, Sanofi, Vertex Pharmaceuticals


                    • © 2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

                    MAT-GLB-2305935 v1.0 12/2023

                    MAT-US-2305475 v1.0 - P Expiration Date: 12/22/2025

                    25 min
                  • Clinical Perspective on Pediatric Patients With Atopic Dermatitis

                    Join Drs. Lisa Swanson and Weily Soong as they provide clinical perspectives on the care of pediatric patients with atopic dermatitis (AD) and discuss unmet needs, addressing coexisting diseases, and the role of the interdisciplinary team and caregivers in the management of AD in pediatric patients.

                    ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

                    This podcast is intended for healthcare professionals only.


                    Disclaimer: 

                    • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
                    • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
                    • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits


                      • Speaker disclosures:

                      • Weily Soong, MD has served as an advisor, consultant, speaker, and/or investigator for Abbvie, Allakos, Amgen, AstraZeneca, Eli Lilly, Incyte, Leo, Pfizer, Regeneron, Sanofi, and UCB
                      • Lisa Swanson, MD has served as a speaker for Abbvie, Almirall, Eli Lilly, Incyte, Janssen, Novartis, Ortho Dermatologics, Pfizer, Sanofi, Regeneron, and Verrica; and as an advisory board consultant for Arcutis, Dermavant, Eli Lilly, Janssen, Leo, Novan, Ortho Dermatologics, Pfizer, Sanofi, Regeneron, and Verrica


                        • © 2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

                        MAT-GLB-2303452 V1 11/2023

                        MAT-US-2305632 v1.0 - P Expiration Date: 11/1/2025

                        17 min
                      • Getting to the Diagnosis of Atopic Dermatitis in Pediatric Patients

                        Learn more about the journey to diagnosis for pediatric patients with atopic dermatitis. Join Drs. Lisa Swanson and Weily Soong as they explore diagnosis and assessment of pediatric atopic dermatitis (AD), determining AD disease severity, and the impact of delayed diagnosis on a patient’s physical and psychological health.

                        ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

                        This podcast is intended for healthcare professionals only.


                        Disclaimer: 

                        • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
                        • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
                        • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits

                          • Speaker disclosures:

                          • Weily Soong, MD has served as an advisor, consultant, speaker, and/or investigator for Abbvie, Allakos, Amgen, AstraZeneca, Eli Lilly, Incyte, Leo, Pfizer, Regeneron, Sanofi, and UCB
                          • Lisa Swanson, MD has served as a speaker for Abbvie, Almirall, Eli Lilly, Incyte, Janssen, Novartis, Ortho Dermatologics, Pfizer, Sanofi, Regeneron, and Verrica; and as an advisory board consultant for Arcutis, Dermavant, Eli Lilly, Janssen, Leo, Novan, Ortho Dermatologics, Pfizer, Sanofi, Regeneron, and Verrica


                            • © 2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

                            MAT-GLB-2303453 V1 10/2023

                            MAT-US-2309379 v1.0 - P Expiration Date: 10/6/2025

                            18 min
                          • Defining Atopic Dermatitis in Pediatric Patients

                            Learn more about the journey for pediatric patients with atopic dermatitis. Join Drs. Lisa Swanson and Weily Soong as they discuss the hallmarks of atopic dermatitis (AD) and explore the clinical presentation, disease trajectories, and burden on patients and caregivers associated with pediatric AD. 

                            ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

                            This podcast is intended for healthcare professionals only.


                            Disclaimer: 

                            • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
                            • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
                            • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits


                              • Speaker disclosures:

                              • Weily Soong, MD has served as an advisor, consultant, speaker, and/or investigator for Abbvie, Allakos, Amgen, AstraZeneca, Eli Lilly, Incyte, Leo, Pfizer, Regeneron, Sanofi, and UCB
                              • Lisa Swanson, MD has served as a speaker for Abbvie, Almirall, Eli Lilly, Incyte, Janssen, Novartis, Ortho Dermatologics, Pfizer, Sanofi, Regeneron, and Verrica; and as an advisory board consultant for Arcutis, Dermavant, Eli Lilly, Janssen, Leo, Novan, Ortho Dermatologics, Pfizer, Sanofi, Regeneron, and Verrica


                                • © 2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

                                MAT-GLB-2303454 V1 10/2023 

                                MAT-US-2305628 v1.0 - P Expiration Date: 8/2/2025

                                19 min
                              • Exploring Common Drivers of Type 2 Inflammatory Diseases

                                Discover shared and unique features of type 2 inflammatory diseases and how multi-disciplinary care can benefit patients. Join Profs. Klaus Rabe and Stephan Weidinger as they explore how chronic underlying type 2 inflammation manifests in different organs to drive pathology in atopic dermatitis, prurigo nodularis, asthma, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis; and discuss how these commonalities translate into shared decision-making and multidisciplinary care in clinical practice.

                                ADVENT is a medical education non-promotional for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.

                                This podcast is intended for healthcare professionals only.


                                Disclaimer: 

                                • This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
                                • The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
                                • The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits


                                  • Speaker disclosures:

                                  • Klaus Rabe, MD, PhD: Grants and research support: German Federal Ministry for Research and Technology (BMFT); Honoraria or consultation fees: AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Menarini, Novartis, Sanofi, Regeneron, Verona Pharma; Other support/potential conflict of interest: Director of the Airway Research Center North (ARCN) within the Deutsche Zentrum für Lungenforschung (DZL)
                                  • Stephan Weidinger, MD, PhD: Speaker, advisory board member, and or investigator for: AbbVie, Almirall, Galderma, Kymab, Leo Pharma, Lilly, Pfizer, Regeneron, Sanofi, Boehringer Ingelheim


                                    • © 2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

                                    MAT-GLB-2302410 v2.0 07/2023

                                    MAT-US-2304930 v1.0-P Exp. Date 07/07/2025

                                    17 min

                                  About ADVENT On Air

                                  From the publisher's feed

                                  The latest updates in type 2 inflammatory science, brought to you by leading experts in the field.